BlackRock Capital Allocation Term Trust (BCAT) to Issue Monthly Dividend of $0.26 on April 30th

BlackRock Capital Allocation Term Trust (NYSE:BCAT) announced a monthly dividend on Friday, February 27th. Shareholders of record on Wednesday, April 15th will be given a dividend of 0.2579 per share on Thursday, April 30th. This represents a c) dividend on an annualized basis and a yield of 20.8%. The ex-dividend date is Wednesday, April 15th.

BlackRock Capital Allocation Term Trust Stock Performance

NYSE:BCAT opened at $14.88 on Monday. The firm has a fifty day simple moving average of $14.76 and a two-hundred day simple moving average of $14.59. BlackRock Capital Allocation Term Trust has a 12 month low of $13.50 and a 12 month high of $15.41.

Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust

A number of large investors have recently bought and sold shares of BCAT. Keener Financial Planning LLC acquired a new stake in BlackRock Capital Allocation Term Trust in the third quarter worth $29,000. Geneos Wealth Management Inc. grew its holdings in BlackRock Capital Allocation Term Trust by 341.7% in the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after purchasing an additional 1,582 shares during the period. N.E.W. Advisory Services LLC grew its holdings in BlackRock Capital Allocation Term Trust by 100.0% in the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock worth $34,000 after purchasing an additional 1,200 shares during the period. AdvisorNet Financial Inc grew its holdings in BlackRock Capital Allocation Term Trust by 53.8% in the third quarter. AdvisorNet Financial Inc now owns 2,995 shares of the company’s stock worth $44,000 after purchasing an additional 1,048 shares during the period. Finally, McIlrath & Eck LLC grew its holdings in BlackRock Capital Allocation Term Trust by 971.1% in the third quarter. McIlrath & Eck LLC now owns 2,999 shares of the company’s stock worth $44,000 after purchasing an additional 2,719 shares during the period. 36.12% of the stock is currently owned by institutional investors and hedge funds.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.